Skip to main content

BlackRock, Inc.

Position in ABT — Abbott Laboratories

CIK 2012383 New York, NY

Position in ABT

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$13,843,609,801
-$1,114,121,501 QoQ
Shares Held
152,563,476
+4.7% QoQ
Ownership
8.76%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1
of 2,957 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Mar 31, 2026
CallValue
$10,934,355
CallShares
106,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $62,872,353,779 across 116 Medical Devices names. ABT ranks #1 (22.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
This page
152,563,476 $13,843,609,801

All Filings in ABT

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,843,609,801 152,563,476
2026-03-31 $10,934,355 106,500
2026-03-31 $14,957,731,302 145,687,458
2025-12-31 $18,406,199,530 146,908,768
2025-09-30 $18,960,540,495 141,559,956
2025-06-30 $19,216,448,396 141,287,026
2025-03-31 $18,170,020,264 136,977,160
2024-12-31 $15,443,425,765 136,534,575
2024-09-30 $14,938,478,440 131,027,791